Not all studies prefer the promotional effect of exosome in immune escape, in some cases, gene-modified tumor cells can cause the TDEs contain glycosyl-phosphatidylinositol-anchored interleukin 2 (GPI-IL-2), resulting in increased antitumor effects and hamper immune escape [71]. Here, IL2 is linked to neoplasm.